| Market Capitalization (Millions $) |
3,620 |
| Shares
Outstanding (Millions) |
68 |
| Employees |
116 |
| Revenues (TTM) (Millions $) |
1 |
| Net Income (TTM) (Millions $) |
-75 |
| Cash Flow (TTM) (Millions $) |
-51 |
| Capital Exp. (TTM) (Millions $) |
0 |
Business Description
Pulse Biosciences Inc is a medical technology company that specializes in developing and commercializing innovative therapies using its proprietary Nano-Pulse Stimulation (NPS) technology. This technology is designed to deliver controlled and high-amplitude nanosecond electrical pulses to treat various medical conditions.
The company primarily focuses on dermatology and aesthetic applications, with its flagship product being the CellFX System. The CellFX System utilizes NPS technology to disrupt targeted cells while sparing surrounding healthy tissue, providing a non-thermal, non-thermal ablative treatment option for dermatologic conditions.
Pulse Biosciences Inc aims to revolutionize the field of medical dermatology by providing physicians and patients with a safe, precise, and effective alternative to traditional treatments. The company continues to invest in research and development to explore new therapeutic applications for its NPS technology beyond dermatology, such as in oncology and cardiology.
Overall, Pulse Biosciences Inc is at the forefront of innovating medical technologies, striving to improve patient outcomes and reshape the approach to treating various health conditions.
Company Address: 601 Brickell Key Drive, Suite 1080 Miami 33131 FL
Company Phone Number: 906-4600 Stock Exchange / Ticker: NASDAQ PLSE
|
6.14% 